The FDA’s removal of black box warnings from hormone replacement therapy (HRT) medications marks a transformative moment in women’s health, reshaping both public perception and clinical practice regarding menopause management and disease prevention.
The FDA’s removal of black box warnings from hormone replacement therapy (HRT) medications marks a transformative moment in women’s health, reshaping both public perception and clinical practice regarding menopause management and disease prevention.